Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis in Type 2 Diabetes Mellitus - A Prospective Study
DOI:
https://doi.org/10.21276/qd8tfx30Keywords:
Non-alcoholic steatohepatitis, Type 2 Diabetes Mellitus, Fatty LiverAbstract
Background: Non-alcoholic steatohepatitis (NASH) is commonly associated with type 2 diabetes mellitus (DM). Prevalence of NASH in type 2 DM has not been well studied and there is an epidemic rise in type 2 DM in Asian and Western populations. Its association with chronic liver disease in the form of NASH makes it an important health problem. Hence we have studied its prevalence and correlation of biochemical parameters with histological grades of non-alcoholic fatty liver disease (NAFLD) in otherwise asymptomatic type 2 DM patients.
Methods: One hundred and forty-eight individuals were screened visiting the Heritage Institute of Medical Sciences, Varanasi. Forty-eight individuals were excluded due to history of alcohol intake or liver disease as a result of other causes. One hundred non-alcoholic individuals with type 2 DM underwent abdominal ultrasonography (US abdomen). Forty-nine patients had evidence of fatty liver on US abdomen, and 32 of these 49 patients underwent liver biopsy.
Results: Four of 32 (12.5%) individuals had steatosis alone. Mild, moderate and severe NASH was present in 21/32 (65.5%), 4/32 (12.5%) and 3/32 (9.35%), respectively. Fibrosis was present in 7/32 (21.8%) patients (four grade 1 and three grade 3). There was no significant difference in body mass index (BMI), transaminase levels, serum cholesterol and triglyceride levels among patients with non-alcoholic fatty liver disease.
Conclusions: We conclude that the prevalence of NASH is high in type 2 DM patients and liver biopsy is the only investigation to differentiate between non-alcoholic fatty liver and steatohepatitis.
Downloads
References
Andrea E. Reid. Nonalcoholic Fatty Liver Disease. Mark Feldman, Lawrence S. Frieddman, Lawrence J. Brandt, editors. Sleisenger and Fordtran’s Gastrointestinal And Liver Disease, 9th ed, Philadelphia, 2010. p 1401-1411.
Stephen H. Caldwell, Curtis K. Argo. Non-alcoholic Fatty Liver Disease and Nutrition. James S. Dooley, Anna S.F. Lok, Andrew K. Burroughs, E. Jenny Heathcote, editors. Sherlock’s Diseases of the Liver and Biliary System, 12th ed, West Sussex,2011.p 546-562.
Yogesh K Chawla, Sunil Taneja. Non-Alcoholic Fatty Liver Disease. YP Munjal, SK Sharma, editors. API Textbook of Medicine, Ninth ed, Mumbai, 2012. p 885-887.
AK Agarwal, Vineet jain, Sumeet Singla, BP Baruah, Vivek Arya, Rajbala Yadav. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. JAPI 2011, 59: 351-354.
Farrell GC, Larter CZ. Nonalcoholic Fatty Liver Disease: from Steatosis to cirrhosis. Hepatology 2006;43:S00-S112.
Lazo M, Clark JM., The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:39-50.
Bellentani S, Scaglioni F, Marino M, Bedogni G., Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28:155-61.
Duseja A., Nonalcoholic fatty liver disease in India - a lot done, yet more required. Indian J Gastroenterol 2010;29:217-25.
Singh SP, Nayak S, Swain M, et al. Prevalence of non-alcoholic fatty liver disease in coastal eastern India: A preliminary ultrsonographic survey. Trop Gastroenterol 2004;25:76-9.
Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009;84:84-91.
Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854–858
Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India 2009;57:205-10.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
